Efficacy of sulbactam for the treatment of Acinetobacter baumannii complex infection: A systematic review and meta-analysis

2017 ◽  
Vol 23 (5) ◽  
pp. 278-285 ◽  
Author(s):  
Haojun Chen ◽  
Qianqian Liu ◽  
Zhanguo Chen ◽  
Congrong Li
Keyword(s):  
Systematic Review ◽  
Acinetobacter Baumannii ◽  
Meta Analysis ◽  
Acinetobacter Baumannii Complex

Rate of polymyxin resistance among Acinetobacter baumannii recovered from hospitalized patients: a systematic review and meta-analysis

2020 ◽  
Vol 39 (8) ◽  
pp. 1427-1438
Author(s):  
William Gustavo Lima ◽  
Júlio César Moreira Brito ◽  
Bárbara Gatti Cardoso ◽  
Valbert Nascimento Cardoso ◽  
Magna Cristina de Paiva ◽  
...  
Keyword(s):  
Systematic Review ◽  
Acinetobacter Baumannii ◽  
Meta Analysis ◽  
Hospitalized Patients

In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: A systematic review and meta-analysis

2015 ◽  
Vol 45 (1) ◽  
pp. 8-18 ◽  
Author(s):  
Wentao Ni ◽  
Xiaodi Shao ◽  
Xiuzhen Di ◽  
Junchang Cui ◽  
Rui Wang ◽  
...  
Keyword(s):  
Systematic Review ◽  
Acinetobacter Baumannii ◽  
Meta Analysis

Systematic Review and Meta-analysis of Carbapenem Resistance of Acinetobacter baumannii in Iran

2020 ◽  
Vol 20 (5) ◽  
pp. 611-619
Author(s):  
Pegah Shakib ◽  
Zeinab Babaie Choolandaimy ◽  
Faranak Rezaie ◽  
Mahmood Bahmani ◽  
Somayeh Delfani
Keyword(s):  
Systematic Review ◽  
Acinetobacter Baumannii ◽  
Web Of Science ◽  
Meta Analysis ◽  
Carbapenem Resistance ◽  
Drug Resistant ◽  
Sample Collection ◽  
Carbapenem Resistant ◽  
Collection Period ◽  
Egger Test

Introduction: The prevalence of carbapenem resistance in Acinetobacter baumannii has been increasing worldwide, and therapeutic options are extremely limited. We performed a systematic review to evaluate the phenotypic and genotypic carbapenem resistance in A.baumannii reported in Iran. Methods: We systematically searched Pub Med, Web of Science Direct, and Google scholar databases to identify studies addressing the carbapenem resistance of A. baumannii. The selected papers were published between 2005 and 2016, but the sample collection period was between 2002 and 2016. To estimate the prevalence, the Der Simonian and Laird randomized models, a 95% confidence interval, was used. For the heterogeneity check, I2 test was used. The Egger test was used to check the propagation bias. Results: Analysis of data indicates that there was an increase in resistance to carbapenems from 4.5% in 2005 to a 100% prevalence rate in 2016 (65.4 (95% CI: 58.8 – 71.6). Conclusion: According to the results of this study, the rate of resistance to carbapenem in A.baumannii has been increasing in Iran. The presence of carbapenem-resistant isolates is a major concern, because carbapenem is the main drug used against Multi Drug Resistant (MDR) isolates.

scholarly journals Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis

2013 ◽  
Vol 17 (4) ◽  
pp. 389-394 ◽  
Author(s):  
Haiqing Chu ◽  
Lan Zhao ◽  
Minggui Wang ◽  
Yang Liu ◽  
Tao Gui ◽  
...  
Keyword(s):  
Systematic Review ◽  
Acinetobacter Baumannii ◽  
Meta Analysis

scholarly journals Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis

2017 ◽  
Vol 73 (1) ◽  
pp. 22-32 ◽  
Author(s):  
Kirati Kengkla ◽  
Khachen Kongpakwattana ◽  
Surasak Saokaew ◽  
Anucha Apisarnthanarak ◽  
Nathorn Chaiyakunapruk
Keyword(s):  
Systematic Review ◽  
Acinetobacter Baumannii ◽  
Meta Analysis ◽  
Treatment Options ◽  
Efficacy And Safety ◽  
Comparative Efficacy
Sign in / Sign up

Export Citation Format

Share Document